诺华-话题@MedSci

#诺华#

235篇内容 | 5387人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1282653, encodeId=cac4128265363, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华ALK阳性肺癌药物Zykadia色瑞替尼获欧洲批准, objectType=article, longId=50626, objectId=d0625062609, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0625062609, replyNumber=0, likeNumber=76, createdTime=2015-05-14, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0625062609, moduleTitle=诺华ALK阳性肺癌药物Zykadia色瑞替尼获欧洲批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0625062609)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282652, encodeId=7eb812826525f, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华重磅药物Jakavi欧盟收获新适应症：真性红细胞增多症（PV）, objectType=article, longId=48434, objectId=d5af48434cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5af48434cb, replyNumber=0, likeNumber=76, createdTime=2015-03-22, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5af48434cb, moduleTitle=诺华重磅药物Jakavi欧盟收获新适应症：真性红细胞增多症（PV）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5af48434cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282651, encodeId=6a3b128265142, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华眼科新药RTH258 II期临床疗效媲美拜耳Eylea, objectType=article, longId=47665, objectId=3c6b4e665fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c6b4e665fd, replyNumber=0, likeNumber=57, createdTime=2015-03-05, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c6b4e665fd, moduleTitle=诺华眼科新药RTH258 II期临床疗效媲美拜耳Eylea, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c6b4e665fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282650, encodeId=8efd12826500a, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=重磅！诺华抗癌药Farydak获FDA批准，系治疗多发性骨髓瘤的HDAC抑制剂, objectType=article, longId=47498, objectId=7e584e4988f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e584e4988f, replyNumber=0, likeNumber=75, createdTime=2015-03-01, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e584e4988f, moduleTitle=重磅！诺华抗癌药Farydak获FDA批准，系治疗多发性骨髓瘤的HDAC抑制剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e584e4988f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282649, encodeId=b2f01282649ac, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华有望迎来美国上市的第一个生物仿制药, objectType=article, longId=45127, objectId=c0654512edd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0654512edd, replyNumber=0, likeNumber=92, createdTime=2015-01-09, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0654512edd, moduleTitle=诺华有望迎来美国上市的第一个生物仿制药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0654512edd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282648, encodeId=eb0612826487a, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华开发抗衰老的灵丹妙药, objectType=article, longId=45030, objectId=544c4503031, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=544c4503031, replyNumber=0, likeNumber=60, createdTime=2015-01-07, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=544c4503031, moduleTitle=诺华开发抗衰老的灵丹妙药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=544c4503031)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282647, encodeId=4fa6128264e9c, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华青光眼药物Travatan（曲伏前列素滴眼液）收获欧盟儿科适应症, objectType=article, longId=44608, objectId=d43d44608a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d43d44608a2, replyNumber=0, likeNumber=48, createdTime=2014-12-27, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d43d44608a2, moduleTitle=诺华青光眼药物Travatan（曲伏前列素滴眼液）收获欧盟儿科适应症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d43d44608a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282646, encodeId=a702128264613, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华治疗肢端肥大症长效药物获得FDA批准, objectType=article, longId=44243, objectId=c3c144243ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3c144243ac, replyNumber=0, likeNumber=70, createdTime=2014-12-20, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3c144243ac, moduleTitle=诺华治疗肢端肥大症长效药物获得FDA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3c144243ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282645, encodeId=8790128264534, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=ASH 2014：诺华filgrastim生物仿制药疗效媲美安进Neupogen, objectType=article, longId=43830, objectId=89874383047, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89874383047, replyNumber=0, likeNumber=0, createdTime=2014-12-12, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89874383047, moduleTitle=ASH 2014：诺华filgrastim生物仿制药疗效媲美安进Neupogen, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89874383047)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282644, encodeId=5dec1282644f0, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=Array BioPharma从诺华手中收回肿瘤药binimetinib授权, objectType=article, longId=43726, objectId=c1da43e26eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1da43e26eb, replyNumber=0, likeNumber=58, createdTime=2014-12-10, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1da43e26eb, moduleTitle=Array BioPharma从诺华手中收回肿瘤药binimetinib授权, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1da43e26eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282643, encodeId=ae85128264305, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华葛兰素史克$220亿资产置换交易或下月获欧盟批准, objectType=article, longId=43487, objectId=55bf4348ee4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55bf4348ee4, replyNumber=0, likeNumber=50, createdTime=2014-12-05, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55bf4348ee4, moduleTitle=诺华葛兰素史克$220亿资产置换交易或下月获欧盟批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55bf4348ee4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282641, encodeId=320c12826411a, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=历史性突破！诺华心衰药LCZ696斩获欧盟心血管历史上加速评估资格, objectType=article, longId=43369, objectId=4f024336900, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f024336900, replyNumber=0, likeNumber=89, createdTime=2014-12-03, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f024336900, moduleTitle=历史性突破！诺华心衰药LCZ696斩获欧盟心血管历史上加速评估资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f024336900)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282642, encodeId=a30f1282642a4, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=医疗领域2宗重大交易获美国反垄断批准：美敦力$430亿收购Covidien，GSK与诺华220$亿资产置换, objectType=article, longId=43372, objectId=64c9433e216, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64c9433e216, replyNumber=0, likeNumber=66, createdTime=2014-12-03, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64c9433e216, moduleTitle=医疗领域2宗重大交易获美国反垄断批准：美敦力$430亿收购Covidien，GSK与诺华220$亿资产置换, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64c9433e216)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282640, encodeId=234612826405e, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=挫折！FDA延长诺华公司多发性骨髓瘤药物panobinostat审批时间, objectType=article, longId=43288, objectId=9f12432880c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f12432880c, replyNumber=0, likeNumber=67, createdTime=2014-11-30, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f12432880c, moduleTitle=挫折！FDA延长诺华公司多发性骨髓瘤药物panobinostat审批时间, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f12432880c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282639, encodeId=6aa01282639c3, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华单抗Cosentyx将于2015年初上市，将成为IL-17阻断剂, objectType=article, longId=43163, objectId=6a714316374, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a714316374, replyNumber=0, likeNumber=141, createdTime=2014-11-28, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a714316374, moduleTitle=诺华单抗Cosentyx将于2015年初上市，将成为IL-17阻断剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a714316374)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282638, encodeId=635412826380b, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=心衰药物LCZ696数据积极令诺华“心跳”加速, objectType=article, longId=42825, objectId=a455428257f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a455428257f, replyNumber=0, likeNumber=55, createdTime=2014-11-21, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a455428257f, moduleTitle=心衰药物LCZ696数据积极令诺华“心跳”加速, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a455428257f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282637, encodeId=f010128263eb3, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=FDA审查诺华新型血液肿瘤药物, objectType=article, longId=42428, objectId=7f704242867, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f704242867, replyNumber=0, likeNumber=79, createdTime=2014-11-13, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f704242867, moduleTitle=FDA审查诺华新型血液肿瘤药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f704242867)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282636, encodeId=706b1282636da, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华单抗secukinumab强直性脊柱炎III期临床大获成功, objectType=article, longId=41756, objectId=a38e41e563a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a38e41e563a, replyNumber=0, likeNumber=77, createdTime=2014-10-29, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a38e41e563a, moduleTitle=诺华单抗secukinumab强直性脊柱炎III期临床大获成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a38e41e563a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282635, encodeId=90581282635c5, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=DA确定罗氏/诺华哮喘重磅药物索雷尔（Xolair）提高心血管风险, objectType=article, longId=40984, objectId=53c6409848a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53c6409848a, replyNumber=0, likeNumber=66, createdTime=2014-10-10, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53c6409848a, moduleTitle=DA确定罗氏/诺华哮喘重磅药物索雷尔（Xolair）提高心血管风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53c6409848a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282634, encodeId=34ac128263476, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华因未及时披露白血病药物副作用而道歉, objectType=article, longId=38706, objectId=9a0e38e06f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a0e38e06f7, replyNumber=0, likeNumber=60, createdTime=2014-08-08, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a0e38e06f7, moduleTitle=诺华因未及时披露白血病药物副作用而道歉, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a0e38e06f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

诺华

2020-05-29发表于威斯康星

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华ALK阳性肺癌药物Zykadia色瑞替尼获欧洲批准

2015-05-14

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华重磅药物Jakavi欧盟收获新适应症：真性红细胞增多症（PV）

2015-03-22

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华眼科新药RTH258 II期临床疗效媲美拜耳Eylea

2015-03-05

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

重磅！诺华抗癌药Farydak获FDA批准，系治疗多发性骨髓瘤的HDAC抑制剂

2015-03-01

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华有望迎来美国上市的第一个生物仿制药

2015-01-09

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华开发抗衰老的灵丹妙药

2015-01-07

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华青光眼药物Travatan（曲伏前列素滴眼液）收获欧盟儿科适应症

2014-12-27

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华治疗肢端肥大症长效药物获得FDA批准

2014-12-20

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

ASH 2014：诺华filgrastim生物仿制药疗效媲美安进Neupogen

2014-12-12

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

Array BioPharma从诺华手中收回肿瘤药binimetinib授权

2014-12-10

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华葛兰素史克$220亿资产置换交易或下月获欧盟批准

2014-12-05

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

历史性突破！诺华心衰药LCZ696斩获欧盟心血管历史上加速评估资格

2014-12-03

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

医疗领域2宗重大交易获美国反垄断批准：美敦力$430亿收购Covidien，GSK与诺华220$亿资产置换

2014-12-03

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

挫折！FDA延长诺华公司多发性骨髓瘤药物panobinostat审批时间

2014-11-30

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华单抗Cosentyx将于2015年初上市，将成为IL-17阻断剂

2014-11-28

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

心衰药物LCZ696数据积极令诺华“心跳”加速

2014-11-21

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

FDA审查诺华新型血液肿瘤药物

2014-11-13

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华单抗secukinumab强直性脊柱炎III期临床大获成功

2014-10-29

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

DA确定罗氏/诺华哮喘重磅药物索雷尔（Xolair）提高心血管风险

2014-10-10

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华因未及时披露白血病药物副作用而道歉

2014-08-08

科室
- - 订阅+
  - 更多科室
工具
服务